These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3476994)

  • 21. Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin.
    Gotthard R; Bodemar G; Brodin U; Jönsson KA
    Scand J Gastroenterol; 1988 Jan; 23(1):7-18. PubMed ID: 3278366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of ecabet sodium on functional dyspepsia: a prospective, double-blinded, randomized, multi-center controlled trial.
    Lee JH; Kim JJ; Hahm KB; Lee DH; Kim N; Kim SK; Park JJ; Choi SR; Lee JH; Lee ST; Lee EH; Rhee JC
    World J Gastroenterol; 2006 May; 12(17):2756-61. PubMed ID: 16718764
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lack of therapeutic effect of cimetidine in non-ulcer dyspepsia.
    Zuberi SJ; Qureshi H; Banatwala NS; Rehman R; Alam E
    J Pak Med Assoc; 1988 Jun; 38(6):168-9. PubMed ID: 3138472
    [No Abstract]   [Full Text] [Related]  

  • 24. Cimetidine or vagotomy? Comparison of the effects of proximal gastric vagotomy, cimetidine and placebo on nocturnal intragastric acidity and acid secretion in patients with cimetidine resistant duodenal ulcer.
    Gledhill T; Buck M; Paul A; Hunt RH
    Br J Surg; 1983 Dec; 70(12):704-6. PubMed ID: 6640248
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cimetidine and non-ulcer dyspepsia.
    Drug Ther Bull; 1986 Jan; 24(1):3-4. PubMed ID: 3516618
    [No Abstract]   [Full Text] [Related]  

  • 26. Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia.
    Rappaport BS
    N Engl J Med; 1986 Sep; 315(12):763-4. PubMed ID: 3528852
    [No Abstract]   [Full Text] [Related]  

  • 27. Nocturnal gastric acid secretion in duodenal ulcer: inhibition by cimetidine.
    Broor SL; Shrestha GP; Mehta SK; Sharma BK
    Am J Med Sci; 1981; 282(3):120-4. PubMed ID: 6797298
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cisapride or cimetidine in the treatment of functional dyspepsia. Results of a double-blind, randomized, Swiss multicentre study.
    Halter F; Miazza B; Brignoli R
    Scand J Gastroenterol; 1994 Jul; 29(7):618-23. PubMed ID: 7939398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are frequent short gastro-oesophageal reflux episodes the cause of symptoms in patients with non-ulcer dyspepsia responding to treatment with ranitidine?
    Farup PG; Hovde O; Breder O
    Scand J Gastroenterol; 1995 Sep; 30(9):829-32. PubMed ID: 8578179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Twenty-four-hour intragastric acidity and nocturnal gastric secretion in gastric ulcer patients--the effects of cimetidine.
    Derodra JK; Howden CW; Burget DW; Hunt RH
    Aliment Pharmacol Ther; 1990 Jun; 4(3):275-81. PubMed ID: 2104090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of Helicobacter pylori infection in non-ulcer dyspepsia.
    Veldhuyzen van Zanten SJ
    Aliment Pharmacol Ther; 1997 Apr; 11 Suppl 1():63-9. PubMed ID: 9146792
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of transdermal scopolamine, alone or in combination with cimetidine, on total 24 hour gastric acid secretion in patients with duodenal ulcer.
    Richardson CT; Feldman M
    Gut; 1986 Dec; 27(12):1493-7. PubMed ID: 3804025
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identifying response to acid suppressive therapy in functional dyspepsia using a random starting day trial--is gastro-oesophageal reflux important?
    Madsen LG; Wallin L; Bytzer P
    Aliment Pharmacol Ther; 2004 Aug; 20(4):423-30. PubMed ID: 15298636
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-ulcer dyspepsia: potential causes and pathophysiology.
    Talley NJ; Phillips SF
    Ann Intern Med; 1988 Jun; 108(6):865-79. PubMed ID: 3285748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long term cimetidine in the management of severe duodenal ulcer dyspepsia.
    Gray GR; Smith IS; Mackenzie I; Gillespie G
    Gastroenterology; 1978 Feb; 74(2 Pt 2):397-401. PubMed ID: 340329
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A preliminary study of gallbladder emptying in non-ulcer dyspepsia].
    Duan LP; Zheng ZT; Li YN
    Zhonghua Nei Ke Za Zhi; 1994 Jan; 33(1):11-4. PubMed ID: 8045179
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secretory abnormalities in functional dyspepsia.
    Nyrén O
    Scand J Gastroenterol Suppl; 1991; 182():25-8. PubMed ID: 1896826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Acid-related disorders].
    Bytzer P
    Ugeskr Laeger; 2008 Feb; 170(7):525-7. PubMed ID: 18291080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of fifteen months of double-blind treatment with cimetidine and placebo on peptic ulcer recurrence.
    Danielsson A; Ek B; Steen L
    Eur J Clin Pharmacol; 1981; 19(5):335-41. PubMed ID: 6786895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Age does not affect basal gastric acid secretion in normal subjects or in patients with acid-peptic disease.
    Collen MJ; Abdulian JD; Chen YK
    Am J Gastroenterol; 1994 May; 89(5):712-6. PubMed ID: 8172143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.